In recent weeks, GSK has begun implementing large-scale job cuts in Belgium and closing a German vaccine site as part of a ...

Virtual cells will still be just computer models. Synthetic biology’s masterpiece—in the word’s original sense of a work ...

GSK's Upper Merion expansion will require demolition and additional construction trade workers before the biopharmaceutical ...

Chai Discovery has announced an expanded collaboration with GSK following a successful laboratory evaluation of its ...

GSK (LSE:GSK) announced a new collaboration with Chai Discovery to apply AI-driven protein design in its drug discovery ...

GSK will invest more than $800 million to expand its biopharmaceutical manufacturing and research operations in Montgomery ...

GSK will invest more than $800 million to expand its Upper Merion, Pennsylvania site into ​a new biopharmaceutical manufacturing and research ‌hub, creating more than 300 jobs over the next five years ...

UPPER MERION TOWNSHIP — GSK will invest more than $800 million to expand its facilities in Upper Merion Township, Montgomery ...

GSK conducted internal wet-lab testing of the designs, finding binders to all tested targets. These results supported GSK?s expansion of its work with Chai into a broader collaboration. The ...

GSK has joined Chai Discovery’s growing roster of Big Pharma clients, signing up to access protein-folding and design models.

Stronger growth, oncology momentum, and deeper AI use support its innovation-led investment case.GSK: Higher income, solid ...

A GSK spokesperson said "greater information and context could have been provided." (Eric Lalmand/Belga Mag/AFP/Getty Images) GSK showed a “totally unacceptable” lack of transparency in its ...